Joint pain: What clinical trials and emerging therapies are being developed?

Joint pain affects millions of people worldwide. It is a disorder that weakens and limits people’s ability to function in everyday life.

Different conventional treatments and emerging therapies are available to combat it. However, they are not always effective and often generate negative side effects.

However, there is hope for those who suffer from these ailments. New advances and emerging research shed light and innovative therapeutic possibilities to cope with this reality. Would you like to know them?

What is joint pain and how does it affect patients?

Today, people of all ages suffer from joint pain caused by a variety of factors, including injuries and Arthritis, Osteoarthritis and other inflammatory diseases.

Those affected suffer pain, stiffness, swelling and difficulty in moving. As a result, they experience a significant effect on their quality of life, daily activities and emotional well-being.

In addition, it can be a symptom of a more serious underlying disease, so it is essential to seek medical attention when it is felt. Proper treatment not only prevents further complications, but also helps to improve day-to-day living.

Conventional treatments for joint pain

Wondering what are the conventional treatments for joint pain? These are the main ones:

• Analgesics. These medications, such as acetaminophen, are used to relieve mild to moderate pain.
• Non-steroidal anti-inflammatory drugs (NSAIDs). An example is ibuprofen and, in general, they reduce inflammation and relieve pain.
• Corticosteroids. These are used to treat acute and chronic inflammation, such as prednisone.
• Physical therapy or physiotherapy. This consists of strengthening and stretching exercises to improve mobility and reduce pain.

Although they are effective for many people, they can have side effects and do not work for all patients. In addition, the first two only provide temporary relief and do not address the causes of the problem.

New clinical trials in joint pain treatment

Clinical trials are key to developing new treatments for this variety of pain. Currently, several are underway to evaluate the safety and efficacy of different novel therapies.

Their purpose differs from case to case:

• Use of biologic medications that can help reduce inflammation in the joints.
• Non-pharmacological therapies, such as acupuncture and physical therapy.
• New ways of administering existing medications to improve their efficacy and reduce side effects.

Clinical trials can determine whether a new treatment is safe and effective before it is made available to the public. This was the case, for example, with OLIMINAFlex, a food supplement that helps to care for joints while relieving aches and pains. Its users therefore obtain clinical guarantees of its positive contribution.

The patented and clinically tested OLIMINAFlex base formula has demonstrated the following data:

*Pain that lasts for at least three months and can be classified into one of the following categories: neuropathic, musculoskeletal, inflammatory and mechanical pain.

Clinical study conducted in 100 patients with a diagnosis of osteoarthritis, over 18 years of age, with “maximum pain” in the last 24 hours greater than 4 on the visual analog pain scale used. Participating investigators Martinez N. Herrera M, Frías L, Provencio M, Fraile R, Pérez Carrión R, Días V. Protocol approved by the Ethics Committee and study conducted according to good clinical practice guidelines and the Declaration of Helsinki.

Emerging therapies for joint pain

The data published by OAFI (Osteoarthritis Foundation International) are as shocking as joint pain is in the lives of those affected:

• In the case of women, the percentage rises to 73 %.
• 68 % of those over 35 years of age suffer from joint pain.

It is clear, therefore, that it is a disorder that affects millions of people around the world. The development of new clinical trials and emerging therapies responds to the need and hope of so many patients: to achieve more effective solutions.

There are previous references that encourage perseverance in this direction. Thus, OLIMINAFlex is a marvelous finding to relieve joint pain with greater efficacy and duration. Although its effects are neither complete nor definitive, its action contributes to improving the lives of those affected, making it an invaluable support.

How OLIMINAFlex can help you

OLIMINAFlex is a useful supplement to soothe joint pain. Its formula is designed to provide relief to patients with arthritis, osteoarthritis, osteoarthritis, osteoarthritis and other joint disorders.

It includes active ingredients such as glucosamine and chondroitin sulfate, known for their anti-inflammatory and analgesic properties. In addition, it complements the significant presence of olimine with hydrolyzed collagen type II, vitamin D and manganese.

The result is a productive contribution to reducing joint inflammation, increasing the production of synovial fluid and lubricating and cushioning the joints. In addition, hydrolyzed collagen helps to improve overall joint health.

Clinical studies have validated that taking OLIMINAFlex regularly can produce a significant reduction in pain and an improvement in joint mobility. It is now a promising, natural and effective option when you suffer from joint pain.

In summary, joint pain affects many people around the world and has a considerable negative impact on their lives. Conventional treatments bring certain improvements, but they are not always adequate or sufficient.

This is why research, innovation and development are so important. There is still much to be discovered about joint pain and how to treat it. As a society, it is urgent that we continue to support these advances. As a patient, ask your doctor what emerging treatments and therapies can help you.